Hypoglycemia, chronic kidney disease, and diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Mayo Clinic proceedings

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mayocp.2014.07.013PMID 25305751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion

  2014cited by this paper
• Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

  2013cited by this paper
• Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.

  2013cited by this paper
• New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.

  2013cited by this paper
• Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

  2013cited by this paper
• US Renal Data System 2012 Annual Data Report.

  2013cited by this paper
• Sodium glucose cotransporter 2 and the diabetic kidney

  2013cited by this paper
• Mechanisms of hypoglycemia-associated autonomic failure in diabetes.

  2013cited by this paper
• Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

  2013cited by this paper
• Presence of Macroalbuminuria Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes

  2013cited by this paper
• Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.

  2013cited by this paper
• Dapagliflozin: a review on efficacy, clinical effectiveness and safety

  2013cited by this paper
• Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia

  2012cited by this paper
• Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review.

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

  2012cited by this paper
• KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.

  2012cited by this paper
• Chronic kidney disease

  2012cited by this paper
• Summary of Recommendation Statements

  2012cited by this paper
• Chronic kidney disease and diabetes.

  2012cited by this paper
• Estimating Equations for Glomerular Filtration Rate in the Era of Creatinine Standardization

  2012cited by this paper
• Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes

  2012cited by this paper
• Managing diabetes in dialysis patients

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

  2012cited by this paper
• Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and Diabetology.

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

  2012cited by this paper
• Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.

  2011cited by this paper
• Hypoglycemia and Cardiovascular Risks

  2011cited by this paper
• In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

  2010cited by this paper
• The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

  2010cited by this paper
• Hypoglycemia, Diabetes, and Cardiovascular Events

  2010cited by this paper
• Severe hypoglycemia and risks of vascular events and death.

  2010cited by this paper
• Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide.

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Exenatide-Associated Ischemic Renal Failure

  2009cited by this paper
• Frequency of hypoglycemia and its significance in chronic kidney disease.

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Three-year efficacy of complex insulin regimens in type 2 diabetes.

  2009cited by this paper
• Exenatide may aggravate moderate diabetic renal impairment: a case report.

  2008cited by this paper
• Hypoglycaemia in Type 2 diabetes

  2008cited by this paper
• Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

  2008cited by this paper
• [Review of the clinical practice guidebook for diagnosis and treatment of chronic kidney disease].

  2008cited by this paper
• A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events

  2007cited by this paper
• Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

  2007cited by this paper
• Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations

  2007cited by this paper
• Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice

  2007cited by this paper
• Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn with continuous glucose monitoring?

  2007cited by this paper
• Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey.

  2006cited by this paper
• Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities.

  2005cited by this paper
• Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

  2004cited by this paper
• Reviews: Use of Insulin and Oral Hypoglycemic Medications in Patients with Diabetes Mellitus and Advanced Kidney Disease

  2004cited by this paper
• Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes

  2004cited by this paper
• Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure.

  2003cited by this paper
• Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity.

  2003cited by this paper
• Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions.

  2003cited by this paper
• Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.

  2003cited by this paper
• Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment

  2001cited by this paper
• Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans.

  2000cited by this paper
• Hypoglycaemia and counterregulation in type 2 diabetes.

  2000cited by this paper
• Drug-induced hypoglycemic coma in 102 diabetic patients.

  1999cited by this paper
• The association between diabetic nephropathy and autonomic nerve function in type 1 diabetic patients.

  1997cited by this paper
• Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.

  1997cited by this paper
• Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia.

  1996cited by this paper
• Intravenous calcitriol normalizes insulin sensitivity in uremic patients.

  1995cited by this paper
• Microalbuminuria and Potential Confounders: A review and some observations on variability of urinary albumin excretion

  1995cited by this paper
• Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on haemodialysis.

  1993cited by this paper
• Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.

  1992cited by this paper
• Glucose and insulin metabolism in uremia.

  1992cited by this paper
• Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy.

  1992cited by this paper
• Hypoglycemia unawareness.

  1991cited by this paper
• Severe Hypoglycemia in Type I Diabetic Patients With Impaired Kidney Function

  1991cited by this paper
• Fatal Hypoglycaemia in Insulin‐treated Diabetes Mellitus: Clinical Features and Neuropathological Changes

  1990cited by this paper
• Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man

  1990cited by this paper
• Glucose Counterregulation and Its Impact on Diabetes Mellitus

  1988cited by this paper
• Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus.

  1988cited by this paper
• Uremic hypoglycemia. A preventable life-threatening complication.

  1984cited by this paper
• Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine intera

  1984cited by this paper
• Spontaneous hypoglycemia in chronic renal failure.

  1978cited by this paper
• Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

  1978cited by this paper
• Hypoglycemia in Compensated Chronic Renal Insufficiency: Substrate Limitation of Gluconeogenesis

  1974cited by this paper
• Plasma aldosterone regulation in anephric man.

  1973cited by this paper

• Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management

  2025cites this paper
• Glucose-containing vs. glucose-free dialysate for patients with maintenance hemodialysis: Study protocol for a multicenter randomized controlled study-GLUMO study

  2025cites this paper
• Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials

  2025cites this paper
• Perception of hyper-/hypoglycemia and its related factors in type 2 diabetes: a continuous glucose monitoring-based prospective observational study

  2025cites this paper
• Effectiveness and Safety of Insulin Glargine 300 U/ml in High-Risk Subgroups (Renal Impairment and Older Age ≥ 70 years) of Insulin-Naïve People with Type 2 Diabetes: A Post hoc Analysis of Real-World ATOS Study

  2025cites this paper
• Wearable electrochemical sensors for real-time monitoring in diabetes mellitus and associated complications

  2024cites this paper
• Burden of impaired awareness of hypoglycemia in people with diabetes undergoing hemodialysis

  2024cites this paper
• HẠ ĐƯỜNG HUYẾT Ở BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TYPE 2 CAO TUỔI CÓ MỨC LỌC CẦU THẬN <60 ML/PHÚT/M2 TẠI BỆNH VIỆN NỘI TIẾT TRUNG ƯƠNG

  2024cites this paper
• Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review

  2024cites this paper
• Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes

  2024cites this paper
• Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function

  2024cites this paper
• Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners

  2024cites this paper
• Active Labeling Correction of Mealtimes and the Appearance of Types of Carbohydrates in Type 1 Diabetes Information Records

  2023cites this paper
• Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review

  2023cites this paper
• Machine learning-based prediction of risk factors for abnormal glycemic control in diabetic cancer patients receiving nutrition support: a case–control study

  2023cites this paper
• Infradiálisis e infecciones como factores de riesgo para hipo e hiperglucemias en pacientes diabéticos, hospitalizados en hemodiálisis crónica

  2023cites this paper
• A Retrospective Combination Health Outcomes Study among Diabetic Patients with Chronic Kidney Disease: A Multi-Level Study

  2022cites this paper
• Nutritional and metabolic management of the diabetic patient with chronic kidney disease and chronic renal failure

  2022cites this paper
• Frequency of Adrenal Insufficiency in Patients With Hypoglycemia in an Emergency Department: A Cross-sectional Study

  2022cites this paper
• Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan

  2022cites this paper
• A comprehensive risk assessment for nocturnal hypoglycemia in geriatric patients with type 2 diabetes: A single-center case-control study.

  2022cites this paper
• Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy.

  2022cites this paper
• Insulin use in chronic kidney disease and the risk of hypoglycemic events

  2022cites this paper
• The risk factors and predictive nomogram of human albumin infusion during the perioperative period of posterior lumbar interbody fusion: a study based on 2015–2020 data from a local hospital

  2021cites this paper
• Evaluation of hypoglycemia

  2021cites this paper
• Sudden Death Associated with Severe Hypoglycemia in a Diabetic Patient During Sensor-Augmented Pump Therapy with the Predictive Low Glucose Management System

  2021cites this paper
• Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005–2017): the International Diabetes Management Practices Study (IDMPS)

  2021cites this paper
• Pathophysiologic Signature of Impending ICU Hypoglycemia in Bedside Monitoring and Electronic Health Record Data: Model Development and External Validation

  2021cites this paper
• The effects of glucose-free and glucose-containing dialysate during dialysis in MHD patients: a prospective cross-over study

  2021cites this paper
• Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial

  2021cites this paper
• Revisiting Role of HbA1c

  2021cites this paper
• Nursing interventions for people with type 1 diabetes and frequent hypoglycaemia.

  2021cites this paper
• Risk of Pregabalin‐Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database

  2021cites this paper
• Nephropathy and chronic renal insufficiency

  2021cites this paper
• Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment

  2020cites this paper
• Impact of Diabetes Complications

  2020cites this paper
• Management of Diabetes Mellitus in Acute and Chronic Cardiorenal Syndromes

  2020cites this paper
• Simultaneous islet-kidney and islet-after-kidney transplantation

  2020cites this paper
• First‐trimester blood urea nitrogen and risk of gestational diabetes mellitus

  2020cites this paper
• Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial Results

  2020cites this paper
• Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial

  2020influential citation
• Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements (SCREAM) project

  2020cites this paper
• Incidence and risk factors associated with hypoglycemia among patients with chronic kidney disease: A systematic review

  2020influential citation
• Utilization patterns of insulin for patients with type 2 diabetes from national health insurance claims data in South Korea

  2019cites this paper
• Acupuncture attenuates renal interstitial fibrosis via the TGF-β/Smad pathway

  2019cites this paper
• Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations

  2019cites this paper
• Management of diabetes mellitus in chronic kidney disease: an overview.

  2019cites this paper
• Salvianolic Acid A Protects the Kidney against Oxidative Stress by Activating the Akt/GSK-3β/Nrf2 Signaling Pathway and Inhibiting the NF-κB Signaling Pathway in 5/6 Nephrectomized Rats

  2019cites this paper
• Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus

  2019cites this paper
• Hypoglycemic episodes are associated with an increased risk of incident frailty among new onset diabetic patients.

  2019cites this paper
• Delphinidin-induced autophagy protects pancreatic β cells against apoptosis resulting from high-glucose stress via AMPK signaling pathway.

  2019cites this paper
• Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end‐stage renal disease: Results from a randomized, phase 3 study

  2019cites this paper
• Why Do Patients With Well-Controlled Vascular Risk Factors Develop Progressive Chronic Kidney Disease?

  2019cites this paper
• The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.

  2018cites this paper
• Xiaokeping-induced autophagy protects pancreatic β-cells against apoptosis under high glucose stress.

  2018cites this paper
• Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats

  2018cites this paper
• Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers

  2018cites this paper
• Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes

  2018cites this paper
• Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study

  2017cites this paper
• Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.

  2017cites this paper
• Current therapeutic approaches in the management of hyperglycemia in chronic renal disease

  2017cites this paper
• HIPOGLICEMIA EM DOENTES DIABÉTICOS IDOSOS: EXPERIÊNCIA DE UMA UNIDADE DE DIABETES | HYPOGLYCEMIA IN ELDERLY DIABETIC PATIENTS: EXPERIENCE IN A DIABETES UNIT

  2017cites this paper
• Effects of Intensive Control of Glycemia on Clinical Kidney Outcomes in Type 2 Diabetes Patients Compared with Standard Control: A Meta-Analysis

  2017cites this paper
• Alteraciones glucémicas en los pacientes con enfermedad renal crónica

  2016cites this paper
• Paroxetine-induced Hypoglycemia in Type 2 Diabetic Patient

  2016cites this paper
• Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment

  2016influential citation
• Anwendung von GLP-1-Rezeptoragonisten bei Patienten mit Niereninsuffizienz – ein Update

  2016cites this paper
• Glycaemic changes in patients with chronic kidney disease.

  2016cites this paper
• Original articleGlycaemic changes in patients with chronic kidney diseaseAlteraciones glucémicas en los pacientes con enfermedad renal crónica

  2016cites this paper
• Effects of exercise on brain functions in diabetic animal models.

  2015cites this paper
• Diabetic Kidney Disease: Much Progress, But Still More to Do

  2015cites this paper
• Hypoglycemia in Patients with Diabetes and Renal Disease

  2015cites this paper